Stem Cell Research & Therapy
-
Stem Cell Allografts Effective for High-Risk AML Subtype
Hematopoietic stem cell transplants are more effective than other standard consolidation therapies for patients with monosomal karyotype acute myeloid leukemia.
Reuters Health Information, May 15, 2012
-
ACC
Hints for Future of Cell Therapy in HF: FOCUS-CCTRN
The largest study to date of autologous bone-marrow-cell therapy in patients with chronic ischemic heart failure has shown no significant effect on the prespecified end points but did suggest an improvement in LVEF that was related to the number of progenitor cells in the bone marrow.
Heartwire, March 24, 2012
-
Transplantation Conditioning in AML and Myelodysplastic Syndrome
Therapeutic Advances in Hematology, February 14, 2012
-
Cellular Therapy After Allogeneic Stem-Cell Transplantation
Therapeutic Advances in Hematology, January 25, 2012
-
Initial Therapy of Mantle Cell Lymphoma
Therapeutic Advances in Hematology, January 19, 2012
-
Management of the Diabetic Foot With Critical Limb Ischemia
Therapeutic Advances in Endocrinology and Metabolism, January 12, 2012
-
Graft-vs-Host Disease and Allogeneic Cell Transplantation
Cancer Control: Journal of the Moffitt Cancer Center, January 1, 2012